Search This Blog

Translate

Search Tool




Apr 22, 2020

Health & Science | About Coronavirus Vaccine by Roche: Coronavirus Vaccine In 12-18 Months Is ‘Ambitious’, Roche CEO Says

Isabel Togoh



Editors' Pick|
Isabel Togoh
Updated Apr 22, 2020, 07:37am EDT

TOPLINE

A coronavirus vaccine is unlikely to be ready before the end of next year, CEO of Swiss pharmaceutical giant Roche suggested, as he called a 12-18 month timeline “ambitious” during the company’s Q1 Earnings call on Wednesday.
(FILE) Coronavirus Research Close To A Vaccine With Italian Company
Getty Images

KEY FACTS

Roche Chief Executive Severin Schwan said the timeline of up to 18 months to develop a coronavirus vaccine was “ambitious.”
He also criticised some existing blood tests that claim to find out if people have had coronavirus as a “disaster”.
Roche is set to release its own antibody test that can help detect whether a person has developed immunity against the virus.
The test could be ready early next month, Roche said, while it is working to get Emergency Use Authorization from the FDA.
Claims of effective ‘at home’ coronavirus testing kits have come under fire, after the U.K. government spent $20 million on unproven tests from China that ended up not working.
What to watch for: The University of Oxford is set to begin human trials of a potential coronavirus vaccine on Thursday.
Key background: The global rush to produce a coronavirus treatment is on, with dozens of firms and scientists including in the U.S., U.K., Europe and China developing and trialling various drugs and vaccines. Scientists at Oxford say an experimental one could be ready by September. Meanwhile, the World Health Organization is working on a timeline of 12 to 18 months for a safe vaccine. It usually takes around 10 years for a vaccine to reach the market as it must go through several phases of trialling.
Big number: $456 million. That’s how much the U.S. government has spent ordering the development of a coronavirus vaccine from Janssen, Johnson & Johnson’s pharmaceutical arm. This is thought to be the biggest amount yet spent on a vaccine development project, Forbes reported last month.
Tangent: Harvard scientists have warned that social distancing measures could last until 2022, if a treatment for coronavirus is not found.
Further reading: The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & Johnson (Forbes)
Coronavirus Drug Update: The Latest Info On Pharmaceutical Treatments And Vaccines (Forbes)
US may have to endure social distancing until 2022 if no vaccine is quickly found, scientists predict (CNN)
Full coverage and live updates on the Coronavirus
Follow me on Twitter. Send me a secure tip.
Isabel Togoh
I am a breaking news reporter for Forbes in London, covering Europe and the U.S. Previously I was a news reporter for HuffPost UK, the Press Association and a night

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.